References
- [1] WHO report, May 2017.
- [2] Tisch M. [Implantable Hearing Devices]. Laryngorhinootologie. (2017) Apr; 96(S01): S84-S102.
- [3] Bravo-Torres, S.; Der-Mussa, C.; Fuentes-Lopez, E. “Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia.” International journal of audiology, 1-8, 2017.
- [4] Zhao, SQ, Ren, R, Han, DM, Li, Y, Ma, XB, Wang, DN, Li, YL. (2017) “The implantation of Bonebridge in bilateral congenital malformation of external and middle ear.” Zhonghua ErBi Yan Hou Tou Jing Wai Ke Za Zhi,. 52(7): p. 512-516.
- [5] Sprinzl GM., Wolf-Magele A. (2016). “The Bonebridge Bone Conduction Hearing Implant: Indication criteria, surgery and a systematic review of the literature.” Clin Otolaryngol. 41(2):131-43. doi: 10.1111/coa.12484.
- [6] Gavilan J, Adunka O, Agrawal S, Atlas M, Baumgartner WD, Brill S, Bruce I, Buchman C, Caversaccio M, De Bodt MT, Dillon M, Godey B, Green K, Gstoettner W, Hagen R, Hagr A, Han D, Kameswaran M, Karltorp E, Kompis M, Kuzovkov V, Lassaletta L, Li Y, Lorens A, Martin J, Manoj M, Mertens G, Mlynski R, Mueller J, O'Driscoll M, Parnes L, Pulibalathingal S, Radeloff A, Raine CH, Rajan G, Rajeswaran R, Schmutzhard J, Skarzynski H, Skarzynski P, Sprinzl G, Staecker H, Stephan K, Sugarova S, Tavora , Usami S, Yanov Y, Zernotti M, Zorowka P, de Heyning PV. “Quality standards for bone conduction implants.” Acta Oto-Laryngologica.135 (12); 1277-1285, 2015.
- [7] Georgescu M., Vrinceanu D., Radulescu L., Tusaliu M., Martu C., Curutiu C., Hussien MD., Budu V. “Microbial biofilms and implantable hearing aids.” Romanian Biotechnological Letters Vol. 22, No. 4, 12681-12686, 2017, ISSN 1224-5984.
- [8] Pirlich M, Dietz A, Meuret S, Hofer M.(2017) “Implantable Bone Conduction and Active Middle Ear Devices.” Laryngorhinootologie. Feb; 96(2): 120-129.
- [9] Volkenstein S., Thomas J.P., Dazert S. (2016) “Bone Conduction and Active Middle Ear Implants.” Laryngorhinootologie. 95(5):352-63. doi: 10.1055/s-0042-104946.
- [10] Bianchin G., Bonali M., Russo M. & Tribi L. “Active bone conduction system: outcomes with the Bonebridge transcutaneous device.” ORL J Otorhinolaryngol Relat Spec, 77(1), 17-26,2015. doi: 10.1159/000371425.
- [11] Tsang W. S., Yu J. K., Bhatia K. S., Wong T. K. & Tong M. C. “The Bonebridge semiimplantable bone conduction hearing device: experience in an Asian patient.” J Laryngol Otol, 127(12), 1214-1221, 2013. doi: 10.1017/s0022215113002144.
- [12] Sprinzl G., Lenarz T., Ernst A., Hagen R., Wolf-Magele A., Mojallal H., Wolframm M. D. “First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy.” Otol Neurotol, 34(6), 1076-1083, 2013. doi: 10.1097/MAO.0b013e31828bb541.